Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia

Baltazar Dias Sanabria; Eduardo Palmegiani; Andressa Fernandes Seron; Yuri Chiarelli Perdomo; Hélio Amante Miot; Paulo Müller Ramos

doi:10.1016/j.jaad.2022.05.026

Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia

J Am Acad Dermatol. 2023 Feb;88(2):436-437. doi: 10.1016/j.jaad.2022.05.026. Epub 2022 May 18.

Authors

Baltazar Dias Sanabria¹, Eduardo Palmegiani², Andressa Fernandes Seron¹, Yuri Chiarelli Perdomo², Hélio Amante Miot³, Paulo Müller Ramos⁴

Affiliations

¹ Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
² Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.
³ Universidade Estadual Paulista - UNESP, Botucatu, São Paulo, Brazil.
⁴ Universidade Estadual Paulista - UNESP, Botucatu, São Paulo, Brazil. Electronic address: dermato.paulo@gmail.com.

PMID: 35597386
DOI: 10.1016/j.jaad.2022.05.026

No abstract available

Keywords: adverse effects; androgenetic alopecia; arrhythmia; blood pressure; edema; headache; hypotension; minoxidil; oral; side effects; tachycardia.

MeSH terms

Administration, Topical
Alopecia / diagnosis
Alopecia / drug therapy
Blood Pressure Monitoring, Ambulatory*
Humans
Male
Minoxidil* / therapeutic use
Prospective Studies
Treatment Outcome
Vasodilator Agents / therapeutic use

Substances

Minoxidil
Vasodilator Agents